A detailed history of Albion Financial Group transactions in Stryker Corp stock. As of the latest transaction made, Albion Financial Group holds 300 shares of SYK stock, worth $117,042. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$117,042
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$315.94 - $371.96 $94,782 - $111,588
300 New
300 $108,000
Q3 2023

Nov 01, 2023

BUY
$266.54 - $302.43 $1,599 - $1,814
6 Added 42.86%
20 $5,000
Q2 2023

Jul 25, 2023

BUY
$271.49 - $305.09 $3,800 - $4,271
14 New
14 $4,000
Q1 2022

May 09, 2022

SELL
$245.33 - $277.77 $33,855 - $38,332
-138 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$236.63 - $276.44 $709 - $829
-3 Reduced 2.13%
138 $37,000
Q2 2021

Aug 12, 2021

BUY
$242.95 - $267.0 $728 - $801
3 Added 2.17%
141 $37,000
Q4 2020

Feb 19, 2021

BUY
$202.01 - $245.04 $27,877 - $33,815
138 New
138 $34,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $148B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.